Cart
sales@molnova.com
L-Tyrosine-O-phosphoric acid
CAS No. 21820-51-9
L-Tyrosine-O-phosphoric acid( ——— )
Catalog No. M38834 CAS No. 21820-51-9
H-Tyr(H2PO3)-OH is a tyrosine derivative.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 9 | In Stock |
|
| 10MG | 10 | In Stock |
|
| 25MG | Get Quote | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameL-Tyrosine-O-phosphoric acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionH-Tyr(H2PO3)-OH is a tyrosine derivative.
-
DescriptionH-Tyr(H2PO3)-OH is a tyrosine derivative.
-
In VitroAmino acids and amino acid derivatives have been commercially used as ergogenic supplements. They influence the secretion of anabolic hormones, supply of fuel during exercise, mental performance during stress related tasks and prevent exercise induced muscle damage. They are recognized to be beneficial as ergogenic dietary substances.
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number21820-51-9
-
Formula Weight261.17
-
Molecular FormulaC9H12NO6P
-
Purity>98% (HPLC)
-
SolubilityDMSO : 33.33 mg/mL (127.62 mM; ultrasonic and adjust pH to 3 with 1 M HCL )
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Luckose F, et al. Effects of amino acid derivatives on physical, mental, and physiological activities. Crit Rev Food Sci Nutr. 2015;55(13):1793-1144.?
molnova catalog
related products
-
TPCK
TPCK is an irreversible inhibitor of chymotrypsin-like proteases that affect cell proliferation apoptosis and tumorigenesis.
-
15-O-Methylgracilifl...
15-O-Methylgraciliflorin F
-
Talacotuzumab
Talacotuzumab (JNJ 56022473) is an IgG1 fully humanized CD123 neutralizing monoclonal antibody containing a modified Fc structure.
